Gestational diabetes: Relevance of diagnostic criteria and preventive strategies for Type 2 diabetes mellitus

被引:14
作者
Agarwal M.M. [1 ]
Dhatt G.S. [2 ]
Zayed R. [3 ]
Bali N. [4 ]
机构
[1] Department of Pathology, Faculty of Medicine, UAE University, Al Ain
[2] Department of Pathology, Tawam Hospital, Al Ain
[3] Department of Preventive Medicine, Al Ain
[4] Department of Obstetrics and Gynecology, Al Ain Hospital, Al Ain
关键词
Diabetes mellitus prevention; Diagnostic criteria; Gestational diabetes;
D O I
10.1007/s00404-007-0334-4
中图分类号
学科分类号
摘要
Objective: Women with gestational diabetes mellitus (GDM) are at risk to develop Type 2 diabetes mellitus (DM2). The aim of this study was to compare the effect of three international diagnostic criteria on the prevalence of GDM with its implications for prevention of DM2 in the population. Materials and methods: One thousand one hundred and seventy-two pregnant women, who underwent the 75-g oral glucose tolerance test for routine, antenatal GDM screening, were classified using the criteria of the American Diabetes Association (ADA), the World Health Organization (WHO) and Australasian Diabetes in Pregnancy Society (ADIPS). The population-attributable risk, (PAR) was used to estimate the proportion of women with DM2 in the community, who may have been identified much in advance for intervention, by a GDM pregnancy. Results: Using the ADA, WHO and ADPIS criteria, respectively: (a) the prevalence of GDM was 166 (14.2%), 242 (20.6%) and 271 (23.1%) (p < 0.0001); (b) The PAR (95% CI) was 42% (31-52%); 51% (39-62%) and 54% (42-64%). Overall, by all three criteria, 132 (11.3%) women had GDM while 859 (73.3%) were without GDM; the remaining 181 (15.4%) women had classification differences between them. Conclusion: The universal acceptance and the ability of the WHO criteria to detect over half the women with DM2 earlier during pregnancy, makes it ideally suited to identify women with GDM. © 2007 Springer-Verlag.
引用
收藏
页码:237 / 243
页数:6
相关论文
共 20 条
[1]  
Wild S., Roglic G., Green A., Sicree R., King H., Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030, Diabetes Care, 27, pp. 1047-1053, (2004)
[2]  
Cheung N.W., Byth K., Population health significance of gestational diabetes, Diabetes Care, 26, pp. 2005-2009, (2003)
[3]  
Greene M.F., Screening for gestational diabetes mellitus, N Engl J Med, 337, pp. 1625-1626, (1997)
[4]  
Kim C., Newton K.M., Knopp R.H., Gestational diabetes and the incidence of type 2 diabetes: A systematic review, Diabetes Care, 25, pp. 1862-1868, (2002)
[5]  
Ben-Haroush A., Yogev Y., Hod M., Epidemiology of gestational diabetes mellitus and its association with Type 2 diabetes, Diabet Med, 21, pp. 103-113, (2004)
[6]  
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin, N Engl J Med, 346, pp. 393-403, (2002)
[7]  
Buchanan T.A., Xiang A.H., Peters R.K., Kjos S.L., Marroquin A., Goico J., Et al., Preservation of pancreatic beta-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk hispanic women, Diabetes, 51, pp. 2796-2803, (2002)
[8]  
Diabetes E-Atlas, 2nd Edn., (2003)
[9]  
Agarwal M.M., Hughes P.F., Punnose J., Ezimokhai M., Fasting plasma glucose as a screening test for gestational diabetes in a multi-ethnic, high-risk population, Diabet Med, 17, pp. 720-726, (2000)
[10]  
Diabetes Mellitus G., Position statement American Diabetes Association, Diabetes Care, 27, (2004)